JP Patent

JP7536036B2 — Ａ２ａ受容体アンタゴニストの塩形態、結晶形態及びその製造方法

Assigned to CStone Pharmaceuticals Shanghai Co Ltd · Expires 2024-08-19 · 2y expired

What this patent protects

Patent listed against tapinarof.

Drugs covered by this patent

tapinarof (TAPINAROF)

Patent Metadata

Patent number: JP7536036B2
Jurisdiction: JP
Classification: —
Expires: 2024-08-19
Drug substance claim: No
Drug product claim: No
Assignee: CStone Pharmaceuticals Shanghai Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.